| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $23.8B | $13.5B | $14.9B |
| Cost of Revenue | $66.9B | $49.7B | $54.7B |
| Gross Profit | $1.0B | $1.1B | $1.3B |
| R&D Expense | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $2.1B | $1.8B | $1.7B |
| Operating Income | — | — | — |
| Net Income | $0.1B | $0.6B | $0.6B |
| EPS (Basic) | $0.49 | $4.41 | $4.24 |
| EPS (Diluted) | $0.49 | $4.36 | $4.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $44.5B | $24.9B | $25.4B |
| Current Assets | $24.4B | $16.0B | $16.4B |
| Cash & Equivalents | $1.1B | $3.3B | $2.6B |
| Total Liabilities | — | — | — |
| Current Liabilities | $15.1B | $7.4B | $7.7B |
| Stockholders' Equity | $15.9B | $9.9B | $10.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.9B | $3.3B |
| Investing Cash Flow | $-5.2B | $-1.1B | $-1.0B |
| Capital Expenditures | $1.7B | $1.4B | $1.1B |
| Financing Cash Flow | $2.2B | $-0.1B | $-0.9B |